Phyllis Yale is currently the Board Chair of Kindred Healthcare (NYSE: KND), Board Chair of Blue Cross Blue Shield of Massachusetts, and a board member of DaVita Healthcare (NYSE: DVA). Over time she has served on four additional corporate boards (NeighborCare, Inc (NASDAQ), Pediatric Services of America (NASDAQ), privately-held Value Options, Inc, and privately held National Surgical Hospials, Inc. She has also served on a number of non-profit boards, including The Bridgespan Group, The United Way of Massachusetts Bay, Cradles to Crayons, Planned Parenthood League of Massachusetts, and others.
She serves on a number of advisory boards, including Alegeus, Inc., the Advisory Board for the HBS Healthcare Initiative, and the Executive Council of the Health Policy Management Department at the Harvard Chan School of Public Health.
Phyllis Yale is an Advisory Partner in Bain & Company’s Boston office. She joined the firm in 1982 and was elected to the partnership in 1987. Ms. Yale has been a leader in building Bain’s health care practice for 30 years. Over her career she has worked with health care payers and with providers across the continuum of care, and she frequently advises the world’s leading private equity firms on their investments in the health care sector. Ms. Yale was awarded a Lifetime Achievement award by Consulting Magazine, and was named by Working Mother magazine as one of the top 25 working mothers. She has published articles in the Harvard Business Review and in Vivo, among other publications, and is a frequent speaker at industry conferences, including The World Economic Forum’s annual meeting in Davos.
She earned an AB from Harvard in Economics, and an MBA from Harvard Business School.
What is Phyllis R. Yale's net worth?
The estimated net worth of Phyllis R. Yale is at least $2.16 million as of May 12th, 2023. Ms. Yale owns 13,110 shares of DaVita stock worth more than $2,160,921 as of December 3rd. This net worth approximation does not reflect any other assets that Ms. Yale may own. Learn More about Phyllis R. Yale's net worth.
How do I contact Phyllis R. Yale?
Has Phyllis R. Yale been buying or selling shares of DaVita?
Phyllis R. Yale has not been actively trading shares of DaVita during the last ninety days. Most recently, Phyllis R. Yale sold 2,196 shares of the business's stock in a transaction on Friday, May 12th. The shares were sold at an average price of $95.26, for a transaction totalling $209,190.96. Following the completion of the sale, the director now directly owns 13,110 shares of the company's stock, valued at $1,248,858.60. Learn More on Phyllis R. Yale's trading history.
Who are DaVita's active insiders?
DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), James Hearty (Chief Compliance Officer), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?
In the last year, insiders at the sold shares 11 times. They sold a total of 313,052 shares worth more than $44,636,354.33. The most recent insider tranaction occured on September, 16th when CEO Javier Rodriguez sold 50,000 shares worth more than $8,252,500.00. Insiders at DaVita own 2.0% of the company.
Learn More about insider trades at DaVita. Information on this page was last updated on 9/16/2024.
